C. Block

Differential glomerular proteome analysis of two murine nephropathy models at onset of albuminuria

K. Amann, T. Fröhlich, N. Herbach, 2011, Proteomics. Clinical applications.

Effectiveness of Additional Risk Minimization Measures for Atezolizumab in the European Union

N. Qizilbash, R. Mutter, I. Méndez, 2021, Pharmaceutical Medicine.

Differential proteomic analysis of isolated glomeruli from two murine nephropathy models at early stages of glomerulosclerosis

C. Block, 2008 .